GUO Fundation
Binary Operation Guide
博文
(2015-03-02 23:24:51)
AFArticleLink[阅读全文]
(2015-02-25 23:49:02)
Readforfun[阅读全文]
(2015-02-25 23:43:43)
AnticipatedNear-TermMilestonesCompletionoffeasibilitystudiesforthehydrogeldepotdeliveringanti-VEGFdrugsincollaborationwithseveralpharmaceuticalpartners,expectedinthefirstquarterof2015.Phase3resultsofOTX-DPforthetreatmentofpost-operativeocularinflammationandpain,expectedinthefirstquarterof2015,andassumingfavorableresultsthesubmissionofanNDAtotheFDA,expectedinthesecondquarterof2015.[阅读全文]
(2015-02-25 23:37:49)
NewLinkGeneticsCorporationReportsThirdQuarter2014FinancialResultsAMES,Iowa,Nov.6,2014(GLOBENEWSWIRE)--NewLinkGeneticsCorporation(Nasdaq:NLNK),todayreportedconsolidatedfinancialresultsforthethirdquarterof2014andprogressinitsclinicalandbusinessdevelopmentprograms."AsweannouncedinAugust,wecontinuetodevelopthesciencearoundcombiningourIDOpathwayproductcandidateswithtreatmentmodalitiesincludingothe...[阅读全文]
(2015-02-25 23:33:23)
"WewereencouragedtofindthattheCTCsub-studyconfirmedthepresenceofseveralpotentialtarget-specificpharmacodynamicbiomarkers,suchastopoisomerase1,inthepatientsenrolledinourstudy,"saidIvanGergel,MD,seniorvicepresidentdrugdevelopmentandchiefmedicalofficerofNektarTherapeutics."TheanalysisfromtheBEACONCTCsub-studycouldhelpusbetterunderstandwhichadditionalpatientpopulationswouldbenefitfromNK...[阅读全文]
(2015-02-25 23:28:14)
UpcomingMilestonesMerrimackanticipatesthefollowingupcomingmilestones:PresentationofupdatedMM-398Phase3NAPOLI-1resultsatASCOGIinJanuary2015;SubmissionofaNewDrugApplicationtotheFDAforMM-398;AnnouncementoftoplinedatafromthePhase2clinicaltrialofMM-111ingastric,esophagealandgastroesophagealcancersin2015;andInitiationofaPhase2clinicaltrialofMM-141infrontlinepancreaticcancerin2015.[阅读全文]
(2015-02-25 23:21:08)
ARRY-797(ARRY-371797)–Phase2trialenrollingpatientswithLMNA-relateddilatedcardiomyopathy(DCM)Arrayisenrollinga12-patientPhase2study(NCT02057341)toevaluatetheeffectivenessandsafetyofARRY-797inpatientswithLMNA-relatedDCM,aserious,geneticcardiovasculardisease.Byage45,approximately70%ofpatientswithLMNA-relatedDCMexperiencecardiovasculardeath,transplantoramajorcardiacevent.Arrayplanstoprovideanupd...[阅读全文]
(2015-02-25 10:58:34)
CLEVELAND,Dec.29,2014(GLOBENEWSWIRE)--Athersys,Inc.(Nasdaq:ATHX)todayannouncedthatithasconcludedpatientenrollmentofitsPhase2clinicalstudyinvolvingadministrationofAthersys'MultiStem®celltherapytoischemicstrokepatients.Thestudyisarandomized,double-blind,placebo-controlled,multi-centerclinicaltrialevaluatingthesafetyandefficacyofMultiStemtherapyinsubjectssufferingmoderatetomoderate-severeischemic...[阅读全文]
(2015-02-24 01:12:27)
ThirdQuarterDevelopmentProgramHighlights
InJuly,EsperioninitiatedenrollmentinETC-1002-014,aPhase2studyin144patientswithhypercholesterolemiaandhypertension.Therandomized,double-blind,parallelgroup,multicenterstudyisevaluating180mgofETC-1002asmonotherapyascomparedwithplaceboforsixweeks.Top-lineresultsareexpectedinQ22015.
OnOctober1st,Esperionannouncedpositivetop-lineresultsfromtheETC-1002-008,Ph...[阅读全文]
(2015-02-24 01:04:11)
Anti-LINGODyaxlicenseeBiogenIdecInc.(Biogen)hasstatedthattheirPhase2clinicaltrialinacuteopticneuritiswithanti-LINGO,afullyhumanmonoclonalantibodythattargetsLINGO-1,isfullyenrolled.Biogenhasalsostatedthattheyexpecttodisclosetop-lineresultsfromthestudy,whichisreferredtoasRENEW,inearly2015.In2013,Biogeninitiatedarandomized,double-blind,parallel-group,dose-rangingPhase2clinicaltrialinvestigatinganti-L...[阅读全文]
